Literature DB >> 7681370

Regulatory implications of good clinical practice. Towards harmonisation.

E F Hvidberg1.   

Abstract

Mesh：

Year:  1993        PMID： 7681370     DOI： 10.2165/00003495-199345020-00002

Source DB:  PubMed          Journal:  Drugs        ISSN： 0012-6667            Impact factor:   9.546


× No keyword cloud information.
  7 in total

1.  Good clinical practice: rules, regulations and their impact on the investigator.

Authors:  M E Allen; M J Vandenburg
Journal:  Br J Clin Pharmacol       Date:  1992-05       Impact factor: 4.335

Review 2.  The regulation of investigational drugs.

Authors:  D A Kessler
Journal:  N Engl J Med       Date:  1989-02-02       Impact factor: 91.245

3.  Good clinical practice and the clinical pharmacologist.

Authors:  A Morice
Journal:  Br J Clin Pharmacol       Date:  1991-11       Impact factor: 4.335

4.  Good clinical practice in clinical research.

Authors:  L Gerlis
Journal:  Lancet       Date:  1989-05-06       Impact factor: 79.321

5.  A comparison of the costs and benefits of recombinant human erythropoietin (epoetin) in the treatment of chronic renal failure in 5 European countries.

Authors:  B Leese; J Hutton; A Maynard
Journal:  Pharmacoeconomics       Date:  1992-05       Impact factor: 4.981

6.  Recombinant granulocyte colony-stimulating factor (rG-CSF): pharmacoeconomic considerations in chemotherapy-induced neutropenia.

Authors:  D Faulds; N J Lewis; R J Milne
Journal:  Pharmacoeconomics       Date:  1992-04       Impact factor: 4.981

7.  Good clinical practice: a way to better drugs.

Authors:  E F Hvidberg
Journal:  BMJ       Date:  1989-09-02
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.